Discovery of tak-272: a novel, potent and orally active renin in-hibitor Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.-C. , Snell, G.P.
Date: 2016-07-01 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 5KOT_A , 5KOT_B
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.-C. , Snell, G.P.
Date: 2016-08-09 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 5SXN_A , 5SXN_B
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.C. , Snell, G.P.
Date: 2016-08-10 Method: X-RAY DIFFRACTION Resolution: 2.25 Å Organism(s): Homo Sapiens Sequences Data: 5SY2_A , 5SY2_B
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.C. , Snell, G.P.
Date: 2016-08-10 Method: X-RAY DIFFRACTION Resolution: 2.3 Å Organism(s): Homo Sapiens Sequences Data: 5SY3_A , 5SY3_B
Structure-based design of a new series of n-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.C. , Snell, G.P.
Date: 2016-08-12 Method: X-RAY DIFFRACTION Resolution: 2.85 Å Organism(s): Homo Sapiens Sequences Data: 5SZ9_A , 5SZ9_B
Novel approach of fragment-based lead discovery applied to renin inhibitors Deposition Author(s): Behnke, C.A. , Lane, W. , Okada, K. , Oki, H. , Sang, B.C. , Snell, G.P.
Date: 2016-08-30 Method: X-RAY DIFFRACTION Resolution: 2.64 Å Organism(s): Homo Sapiens Sequences Data: 5T4S_A , 5T4S_B
Optimization of 3,5-disubstitued piperidine: discovery of non-peptide mimetics as an orally active renin inhibitor Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.C. , Snell, G.P.
Date: 2016-10-12 Method: X-RAY DIFFRACTION Resolution: 2.2 Å Organism(s): Homo Sapiens Sequences Data: 5TMG_A , 5TMG_B
Optimization of 3,5-disubstitued piperidine: discovery of non-peptide mimetics as an orally active renin inhibitor Deposition Author(s): Behnke, C.A. , Hideyuki, O. , Lane, W. , Okada, K. , Sang, B.C. , Snell, G.P.
Date: 2016-10-13 Method: X-RAY DIFFRACTION Resolution: 2.65 Å Organism(s): Homo Sapiens Sequences Data: 5TMK_A , 5TMK_B
Structure-based drug design of novel ask1 inhibitors using a fully integrated lead optimization strategy Deposition Author(s): Dougan, D.R. , Lane, W. , Lawson, J.D.
Date: 2017-03-01 Method: X-RAY DIFFRACTION Resolution: 3.1 Å Organism(s): Homo Sapiens Sequences Data: 5V19_A , 5V19_B
The crystal structure of human s-adenosylhomocysteine hydrolase (ahcy) bound to oxadiazole inhibitor Deposition Author(s): Dougan, D.R. , Lane, W. , Lawson, J.D.
Date: 2017-06-09 Method: X-RAY DIFFRACTION Resolution: 2.4 Å Organism(s): Homo Sapiens Sequences Data: 5W49_A , 5W49_B